Mereo BioPharma (MREO) Amortizatization of Intangibles (2023 - 2026)

Mereo BioPharma (MREO) has reported Amortizatization of Intangibles for 4 consecutive years, with $134000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 1.47% year-over-year to $134000.0 in Q2 2026; TTM through Jun 2026 was $533000.0, a 3.09% increase from a year earlier, with the FY2025 full-year figure at $527000.0, up 3.94% from the prior year.
• Amortizatization of Intangibles was $134000.0 for Q2 2026 at Mereo BioPharma, roughly flat from $134000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $136000.0 in Q2 2025 and troughed at $121000.0 in Q1 2023.
• A 4-year average of $128357.1 and a median of $126000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles climbed 7.94% in 2025 and slipped 1.47% in 2026, its largest moves.
• Over 4 years, Amortizatization of Intangibles stood at $124000.0 in 2023, then grew by 1.61% to $126000.0 in 2024, then grew by 4.76% to $132000.0 in 2025, then increased by 1.52% to $134000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $134000.0 (Q2 2026), $134000.0 (Q1 2026), and $132000.0 (Q4 2025), per Business Quant data.